Levodopa/carbidopa/entacapone in Parkinson's disease. Expert Rev Neurother
Seeberger, LC, and RA Hauser. 2009. “Levodopa/Carbidopa/Entacapone in Parkinson’s Disease. Expert Rev Neurother”. Expert Rev Neurother.
Search
Search results
1934 results found
Sleep disorders in Parkinson’s disease.
Jahan, I, RA Hauser, KL Sullivan, A Miller, and TA Zesiewicz. 2009. “Sleep Disorders in Parkinson’s Disease.”. Neuropsychiatr Dis Treat.
GCH1 in early-onset Parkinson's disease.
Cobb, SA, C Wider, OA Ross, IF Mata, CH Adler, A Rajput, AH Rajput, et al. 2009. “GCH1 in Early-Onset Parkinson’s Disease.”. Mov Disord.
Adenosine, adenosine A2A antagonists, and Parkinson's disease.
Jenner, P, A Mori, RA Hauser, M Morelli, BB Fredholm, and JF Chen. 2009. “Adenosine, Adenosine A2A Antagonists, and Parkinson’s Disease.”. Parkinsonism Relat Disord.
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease
Kordower, JH, Y Chu, RA Hauser, TB Freeman, and CW Olanow. 2008. “Lewy Body-Like Pathology in Long-Term Embryonic Nigral Transplants in Parkinson’s Disease”. Nat Med.
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
Brin, MF, CL Comella, J Jankovic, F Lai, M Naumann, and BoNTA Study Group. 2008. “Long-Term Treatment With Botulinum Toxin Type A in Cervical Dystonia Has Low Immunogenicity by Mouse Protection Assay.”. Mov Disord.
Transplanted dopaminergic neurons develop PD pathologic changes: a second case report
Kordower, JH, Y Chu, RA Hauser, CW Olanow, and TB Freeman. 2008. “Transplanted Dopaminergic Neurons Develop PD Pathologic Changes: A Second Case Report”. Mov Disord.
Pregabalin (Lyrica) in the treatment of Essential Tremor.
Zesiewicz, TA, CL Ward, RA Hauser, JA Pease Campbell, and KL Sullivan. 2007. “Pregabalin (Lyrica) in the Treatment of Essential Tremor.”. Movement Disorders.
Duodenal levodopa infusion for the treatment of Parkinson’s disease.
Samanta, J, and RA Hauser. 2007. “Duodenal Levodopa Infusion for the Treatment of Parkinson’s Disease.”. Expert Opinion Pharmacother.
Advances in the pharmacologic management of early Parkinson’s Disease.
Hauser, RA, and TA Zesiewicz. 2007. “Advances in the Pharmacologic Management of Early Parkinson’s Disease.”. Neurologist.